Episode Details
Back to EpisodesHER2+ Lung Cancer Breakthroughs: Sequencing Therapies and Next-Gen Innovations
Episode 596
Published 7 months, 3 weeks ago
Description
Drs. Herzberg and Yu continue their discussion on emerging clinical data presented at ESMO and WCLC 2025. They highlight recent advancements in HER2-targeted therapies for NSCLC and review new HER2-targeted therapies, international study results, and the promise of evolving targeted approaches for HER2-altered lung cancer.